PUBLIC CONTRACT · 2025
Aquisição de emicizumab 150 mg/ml sol inj fr 1 ml sc - Aq 2023/304 - Adicionais 2025
- Contract value
- €128,867.10
- Signed on
- 23 December 2025
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 12199523PUBLISHED SUBJECT
AQUISIÇÃO DE EMICIZUMAB 150 MG/ML SOL INJ FR 1 ML SC - AQ 2023/304 - ADICIONAIS 2025
Parties involved
- Place of performance
- Portugal, Lisboa, Lisboa
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- ROCHE FARMACEUTICA QUIMICA, LDA · Tax ID 500233810
Values and timeline
- Contract price
- €128,867.10
- Procedure base price
- €128,867.10
- Total effective price
- Not reported on Portal BASE
- Publication date
- 26 December 2025
- Award date
- 23 December 2025
- Signing date
- 23 December 2025
- Performance period
- 8 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- 304/2023 - Medicamentos do grupo 4: sangue
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 8233311
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.